week two semaglutide 2·4 mg once a in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Weight Loss journey | Semaglutide

Compounded GLP-1 drugs are going away Suggested Caption: The shortage of name-brand GLP-1 drugs has ended, and less expensive compounded GLP-1 drugs will no longer be available

Eli Lilly and Company Reports Phase 3 TRIUMPH-1 Trial Shows Up to 30.3% Weight Loss with Retatrutide in Obesity

This helps to increase insulin release after eating, lower glucagon levels, and slow down the emptying of the stomach, all of which contribute to improved blood sugar levels

Comparing Saxenda (liraglutide) and Wegovy (semaglutide)

Understanding Semaglutide: A Powerful Tool for Weight Management Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonista medication that mimics a natural hormone regulating blood sugar and appetite

What to keep in mind if you're concerned about access to your medication.